For best experience please turn on javascript and use a modern browser!
Bekijk de site in het Nederlands

The accurate prediction of preterm births is a big clinical challenge within obstetrics. Most women who present with symptoms of preterm labour do not go on to deliver within one week and the majority will even deliver at term. Correct discrimination between women with a high and low risk of short-term delivery would enable targeted interventions and transfers to improve neonatal outcomes and would also reduce overtreatment and unnecessary health care costs. Fetal fibronectin (fFN) is the most commonly used biomarker in tests aimed predicting preterm birth. Merel Bruijn evaluates a qualitative and quantitative form of fFN test, the aim being to establish the best approach for individualised risk assessment.

Event details of Predicting the chances of preterm birth
Date 9 November 2016
Time 14:00 -15:00
Location Agnietenkapel
Room Location

M.M.C.  Bruijn: Fetal Fibronectin in the Prediction of Preterm Birth.

Supervisor

Prof. B.W.J. Mol

Co-supervisors

Dr G.J. van Baaren

Dr M. Kok

Agnietenkapel

Room Location

Oudezijds Voorburgwal 229 - 231
1012 EZ Amsterdam

Entrance

This event is open to the public.